Related references
Note: Only part of the references are listed.Design and development of novel inhibitors of aldo-ketoreductase 1C1 as potential lead molecules in treatment of breast cancer
Priyanka Verma et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2021)
Pro-inflammatory signals induce 20α-HSD expression in myometrial cells: A key mechanism for local progesterone withdrawal
Lubna Nadeem et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
AKR1C1 Contributes to Cervical Cancer Progression via Regulating TWIST1 Expression
Xing Wei et al.
BIOCHEMICAL GENETICS (2021)
Upregulation of AKR1C1 in mesenchymal stromal cells promotes the survival of acute myeloid leukaemia cells
Yajing Jiang et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Loss of AKR1C1 is a good prognostic factor in advanced NPC cases and increases chemosensitivity to cisplatin in NPC cells
Chen Zhou et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Overview of AKR1C3: Inhibitor Achievements and Disease Insights
Yang Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Role of human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C3) in the extrahepatic metabolism of the steroidal aromatase inactivator Formestane
Runlan Wan et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2020)
Aldo-Keto Reductase 1C1 (AKR1C1) as the First Mutated Gene in a Family with Nonsyndromic Primary Lipedema
Sandro Michelini et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Upregulation of lipid metabolism genes in the breast prior to cancer diagnosis
Natascia Marino et al.
NPJ BREAST CANCER (2020)
Transcript Levels of Aldo-Keto Reductase Family 1 Subfamily C (AKR1C) Are Increased in Prostate Tissue of Patients with Type 2 Diabetes
Andras Franko et al.
JOURNAL OF PERSONALIZED MEDICINE (2020)
Concurrent Mutations in STK11 and KEAP1 Promote Ferroptosis Protection and SCD1 Dependence in Lung Cancer
Corrin A. Wohlhieter et al.
CELL REPORTS (2020)
Use of AKR1C1 and TKTL1 in the Diagnosis of Low-grade Squamous Intraepithelial Lesions from Mexican Women
Alfonso Sequeda-Juarez et al.
ANTICANCER RESEARCH (2020)
The SIRT2-mediated deacetylation of AKR1C1 is required for suppressing its pro-metastasis function in Non-Small Cell Lung Cancer
Hong Zhu et al.
THERANOSTICS (2020)
Avasimibe inhibits tumor growth by targeting FoxM1-AKR1C1 in osteosarcoma
Liang Wang et al.
ONCOTARGETS AND THERAPY (2019)
Targeted Delivery of Zoledronate to Tumor-Associated Macrophages for Cancer Immunotherapy
Xinlong Zang et al.
MOLECULAR PHARMACEUTICS (2019)
AKR1C1 controls cisplatin-resistance in head and neck squamous cell carcinoma through cross-talk with the STAT1/3 signaling pathway
Wei-Min Chang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Identification of gene and microRNA changes in response to smoking in human airway epithelium by bioinformatics analyses
Jizhen Huang et al.
MEDICINE (2019)
Liquiritin, as a Natural Inhibitor o f AKR1C1, Could Interfere With the Progesterone Metabolism
Chenming Zeng et al.
FRONTIERS IN PHYSIOLOGY (2019)
Correlation of NRF2 and progesterone receptor and its effects on ovarian cancer biology
Bastian Czogalla et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Circular RNAs in drug resistant tumors
Xin Hua et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis
Mara Gagliardi et al.
CELL DEATH & DISEASE (2019)
YTHDF1 links hypoxia adaptation and non-small cell lung cancer progression
Yulin Shi et al.
NATURE COMMUNICATIONS (2019)
Upregulation of AKR1C1 and AKR1C3 expression in OPSCC with integrated HPV16 and HPV-negative tumors is an indicator of poor prognosis
Christian U. Huebbers et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Primary open-angle glaucoma
S. Bertaud et al.
REVUE DE MEDECINE INTERNE (2019)
Immunohistochemical predictive markers of response to conservative treatment of endometrial hyperplasia and early endometrial cancer: A systematic review
Antonio Travaglino et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2019)
AKR1C enzymes sustain therapy resistance in paediatric T-ALL
Roberta Bortolozzi et al.
BRITISH JOURNAL OF CANCER (2018)
Carbonyl reduction of NNK by recombinant human lung enzymes: identification of HSD17β12 as the reductase important in (R)-NNAL formation in human lung
Joseph H. Ashmore et al.
CARCINOGENESIS (2018)
Effect of particulate matter 2.5 on gene expression profile and cell signaling in JEG-3 human placenta cells
Woong Kim et al.
ENVIRONMENTAL TOXICOLOGY (2018)
Regulation of prostate cancer by hormone-responsive G protein-coupled receptors
Wei Wang et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Testosterone metabolites inhibit proliferation of castration- and therapy-resistant prostate cancer
Felix Bremmer et al.
Oncotarget (2018)
AKR1C1 Activates STAT3 to Promote the Metastasis of Non-Small Cell Lung Cancer
Hong Zhu et al.
THERANOSTICS (2018)
The Polycystic Ovary Syndrome and the Metabolic Syndrome: A Possible Chronobiotic-Cytoprotective Adjuvant Therapy
Eduardo Spinedi et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2018)
Role of Human Aldo-Keto Reductases in the Metabolic Activation of the Carcinogenic Air Pollutant 3-Nitrobenzanthrone
Jessica R. Murray et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2018)
Pharmacogenetics of aldo-keto reductase 1C (AKR1C) enzymes
Osama Y. Alshogran
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2017)
Long-chain fatty acids inhibit human members of the aldo-keto reductase 1C subfamily
Akira Hara et al.
JOURNAL OF BIOCHEMISTRY (2017)
Adipocytes Sequester and Metabolize the Chemotherapeutic Daunorubicin
Xia Sheng et al.
MOLECULAR CANCER RESEARCH (2017)
Loss of luteotropic prostaglandin E plays an important role in the regulation of luteolysis in women
Junko Nio-Kobayashi et al.
MOLECULAR HUMAN REPRODUCTION (2017)
Mefenamic acid enhances anticancer drug sensitivity via inhibition of aldo-keto reductase 1C enzyme activity
Masashi Shiiba et al.
ONCOLOGY REPORTS (2017)
Spheroid growth in ovarian cancer alters transcriptome responses for stress pathways and epigenetic responses
Trillitye Paullin et al.
PLOS ONE (2017)
Progesterone suppresses the invasion and migration of breast cancer cells irrespective of their progesterone receptor status - a short report
Mukul Godbole et al.
CELLULAR ONCOLOGY (2017)
Aldo-Keto Reductase AKR1C1-AKR1C4: Functions, Regulation, and Intervention for Anti-cancer Therapy
Chen-Ming Zeng et al.
FRONTIERS IN PHARMACOLOGY (2017)
Sex hormones reduce NNK detoxification through inhibition of short-chain dehydrogenases/reductases and aldo-keto reductases in vitro
Claudia Stapelfeld et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2017)
Different inhibitory potential of sex hormones on NNK detoxification in vitro: A possible explanation for gender-specific lung cancer risk
Claudia Stapelfeld et al.
CANCER LETTERS (2017)
The role of Nrf2 and ATF2 in resistance to platinum-based chemotherapy
Jianli Chen et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Stromal markers AKR1C1 and AKR1C2 are prognostic factors in primary human breast cancer
Antonia Wenners et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2016)
Endocrinology of human parturition
Silvia Vannuccini et al.
ANNALES D ENDOCRINOLOGIE (2016)
Mechanism of progestin resistance in endometrial precancer/cancer through Nrf2-AKR1C1 pathway
Yiying Wang et al.
ONCOTARGET (2016)
The roles of AKR1C1 and AKR1C2 in ethyl-3,4-dihydroxybenzoate-induced esophageal squamous cell carcinoma cell death
Wei Li et al.
ONCOTARGET (2016)
Aldo-keto reductase 1C1 induced by interleukin-1β mediates the invasive potential and drug resistance of metastatic bladder cancer cells
Ryuji Matsumoto et al.
SCIENTIFIC REPORTS (2016)
Hormone-related pathways and risk of breast cancer subtypes in African American women
Stephen A. Haddad et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
In vitro inhibition of AKR1Cs by sulphonylureas and the structural basis
Yining Zhao et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2015)
Ruthenium complexes as inhibitors of the aldo-keto reductases AKR1C1-1C3
Katja Traven et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2015)
The aldo-keto reductases (AKRs): Overview
Trevor M. Penning
CHEMICO-BIOLOGICAL INTERACTIONS (2015)
Promiscuity and diversity in 3-ketosteroid reductases
Trevor M. Penning et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2015)
Updated survey of the steroid-converting enzymes in human adipose tissues
Andre Tchernof et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2015)
Exposure to airborne PM2.5 suppresses microRNA expression and deregulates target oncogenes that cause neoplastic transformation in NIH3T3 cells
Chunling Liu et al.
ONCOTARGET (2015)
Activation of AKR1C1/ERβ induces apoptosis by downregulation of c-FLIP in prostate cancer cells: A prospective therapeutic opportunity
Huiyoung Yun et al.
ONCOTARGET (2015)
In vitro metabolism of a novel JNK inhibitor tanzisertib: interspecies differences in oxido-reduction and characterization of enzymes involved in metabolism
Christian Atsriku et al.
XENOBIOTICA (2015)
Induction of aldo-keto reductases (AKR1C1 and AKR1C3) abolishes the efficacy of daunorubicin chemotherapy for leukemic U937 cells
Toshiyuki Matsunaga et al.
ANTI-CANCER DRUGS (2014)
Determination of Sulfotransferase Forms Involved in the Metabolic Activation of the Genotoxicant 1-Hydroxymethylpyrene Using Bacterially Expressed Enzymes and Genetically Modified Mouse Models
Carolin Bendadani et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2014)
Human Aldo-Keto Reductases and the Metabolic Activation of Polycyclic Aromatic Hydrocarbons
Trevor M. Penning
CHEMICAL RESEARCH IN TOXICOLOGY (2014)
The role of carbonyl reducing enzymes in oxcarbazepine in vitro metabolism in man
Petra Malatkova et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2014)
GENDER-SPECIFIC ASSOCIATION OF VARIANTS IN THE AKR1C1 GENE WITH DIMENSIONAL ANXIETY IN PATIENTS WITH PANIC DISORDER: ADDITIONAL EVIDENCE FOR THE IMPORTANCE OF NEUROSTEROIDS IN ANXIETY?
Carina Quast et al.
DEPRESSION AND ANXIETY (2014)
Deeper Insight into the Reducing Biotransformation of Bupropion in the Human Liver
Lucie Skarydova et al.
DRUG METABOLISM AND PHARMACOKINETICS (2014)
A Prolyl-Hydroxylase Inhibitor, Ethyl-3,4-Dihydroxybenzoate, Induces Cell Autophagy and Apoptosis in Esophageal Squamous Cell Carcinoma Cells via Up-Regulation of BNIP3 and N-myc Downstream-Regulated Gene-1
Bo Han et al.
PLOS ONE (2014)
Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism
Tea Lanisnik Rizner et al.
STEROIDS (2014)
Gene expression profiling for analysis acquired oxaliplatin resistant factors in human gastric carcinoma TSGH-S3 cells: The role of IL-6 signaling and Nrf2/AKR1C axis identification
Chih-Cheng Chen et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Progestin effects on expression of AKR1C1-AKRIC3, SRD5A1 and PGR in the Z-12 endometriotic epithelial cell line
Natasa Beranic et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2013)
Pathophysiological roles of aldo-keto reductases (AKR1C1 and AKR1C3) in development of cisplatin resistance in human colon Cancers
Toshiyuki Matsunaga et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2013)
Hepatitis B Virus X Protein Up-Regulates AKR1C1 Expression Through Nuclear Factor-Y in Human Hepatocarcinoma Cells
Kai Li et al.
HEPATITIS MONTHLY (2013)
AKR1C3 as a target in castrate resistant prostate cancer
Adegoke O. Adeniji et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2013)
Deconvoluting complex tissues for expression quantitative trait locus-based analyses
Ji-Heui Seo et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2013)
Role of carbonyl reducing enzymes in the phase I biotransformation of the non-steroidal anti-inflammatory drug nabumetone in vitro
Lucie Skarydova et al.
XENOBIOTICA (2013)
Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profiles
Abena S. Agyeman et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Methyljasmonate displays in vitro and in vivo activity against multiple myeloma cells
Steffen Klippel et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Androgen metabolism and JAK/STAT pathway genes and prostate cancer risk
Erika M. Kwon et al.
CANCER EPIDEMIOLOGY (2012)
Genetic Polymorphisms in Oxidative Stress Pathway Genes and Modification of BMI and Risk of Non-Hodgkin Lymphoma
Christopher Kim et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
9,10-Phenanthrenequinone promotes secretion of pulmonary aldo-keto reductases with surfactant
Toshiyuki Matsunaga et al.
CELL AND TISSUE RESEARCH (2012)
Formation of a 3,4-diol-1,2-epoxide metabolite of benz[a]anthracene with cytotoxicity and genotoxicity in a human in vitro hepatocyte culture system
Mi-Kyung Song et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2012)
Transactivation activity of human papillomavirus type 16 E6☆I on aldo-keto reductase genes enhances chemoresistance in cervical cancer cells
Panata Wanichwatanadecha et al.
JOURNAL OF GENERAL VIROLOGY (2012)
Selective Inhibitors of Aldo-Keto Reductases AKR1C1 and AKR1C3 Discovered by Virtual Screening of a Fragment Library
Petra Brozic et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
The expression of sex steroid synthesis and inactivation enzymes in subcutaneous adipose tissue of PCOS patients
Lihua Wang et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2012)
Expression of human aldo-keto reductase 1C2 in cell lines of peritoneal endometriosis: Potential implications in metabolism of progesterone and dydrogesterone and inhibition by progestins
Natasa Beranic et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2012)
Metabolism of the synthetic progestogen norethynodrel by human ketosteroid reductases of the aldo-keto reductase superfamily
Yi Jin et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2012)
Carcinogenicity of diesel-engine and gasoline-engine exhausts and some nitroarenes
Lamia Benbrahim-Tallaa et al.
LANCET ONCOLOGY (2012)
Enzymes of the AKR1B and AKR1C subfamilies and uterine diseases
Tea Lanisnik Rizner
FRONTIERS IN PHARMACOLOGY (2012)
Retinaldehyde is a substrate for human aldo-keto reductases of the 1C subfamily
F. Xavier Ruiz et al.
BIOCHEMICAL JOURNAL (2011)
Stereospecific reduction of 5β-reduced steroids by human ketosteroid reductases of the AKR (aldo-keto reductase) superfamily: role of AKR1C1-AKR1C4 in the metabolism of testosterone and progesterone via the 5β-reductase pathway
Yi Jin et al.
BIOCHEMICAL JOURNAL (2011)
Probing the inhibitor selectivity pocket of human 20α-hydroxysteroid dehydrogenase (AKR1C1) with X-ray crystallography and site-directed mutagenesis
Ossama El-Kabbani et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Impaired neurosteroid synthesis in multiple sclerosis
Farshid Noorbakhsh et al.
BRAIN (2011)
Progestins as inhibitors of the human 20-ketosteroid reductases, AKR1C1 and AKR1C3
N. Beranic et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2011)
Activities of aldo-keto reductase 1 enzymes on two inhaled corticosteroids: Implications for the pharmacological effects of inhaled corticosteroids
Yi Jin
CHEMICO-BIOLOGICAL INTERACTIONS (2011)
Aldo-keto reductases AKR1C1, AKR1C2 and AKR1C3 may enhance progesterone metabolism in ovarian endometriosis
N. Hevir et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2011)
Inhibitors of Aldo-Keto Reductases AKR1C1-AKR1C4
P. Brozic et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Inhibitors of human 20α-hydroxysteroid dehydrogenase (AKR1C1)
Ossama El-Kabbani et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2011)
Human hydroxysteroid dehydrogenases and pre-receptor regulation: Insights into inhibitor design and evaluation
Trevor M. Penning
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2011)
Inhibitors of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3): Overview and structural insights
Michael C. Byrns et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2011)
Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy
Adam Lister et al.
MOLECULAR CANCER (2011)
Factorizing the role of a critical leucine residue in the binding of substrate to human 20α-hydroxysteroid dehydrogenase (AKR1C1): Molecular modeling and kinetic studies of the Leu308Val mutant enzyme
Urmi Dhagat et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Upregulated Expression of hITF in Crohn's Disease and Screening of hITF Interactant by a Yeast Two-Hybrid System
Huaxiu Shi et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Structure-based optimization and biological evaluation of human 20α-hydroxysteroid dehydrogenase (AKR1C1) salicylic acid-based inhibitors
Ossama El-Kabbani et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Single Nucleotide Differences (SNDs) in the dbSNP Database May Lead to Errors in Genotyping and Haplotyping Studies
Lucia Musumeci et al.
HUMAN MUTATION (2010)
Naturally Occurring Variants of Human Aldo-Keto Reductases with Reduced In Vitro Metabolism of Daunorubicin and Doxorubicin
Onkar S. Bains et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Aldo-keto reductase 1C3 expression in MCF-7 cells reveals roles in steroid hormone and prostaglandin metabolism that may explain its over-expression in breast cancer
Michael C. Byrns et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)
Heterogeneity of gene expression in stromal fibroblasts of human breast carcinomas and normal breast
M. Bauer et al.
ONCOGENE (2010)
Modeling Single Nucleotide Polymorphisms in the Human AKR1C1 and AKR1C2 Genes: Implications for Functional and Genotyping Analyses
Jonathan W. Arthur et al.
PLOS ONE (2010)
Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer
Karen E. Knudsen et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2010)
Long-term In Vitro Treatment of Human Glioblastoma Cells with Temozolomide Increases Resistance In Vivo through Up-regulation of GLUT Transporter and Aldo-Keto Reductase Enzyme AKR1C Expression
Benjamin Le Calve et al.
NEOPLASIA (2010)
Role of CYP27A1 in progesterone metabolism in vitro and in vivo
Genevieve Escher et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Steroid Hormone Transforming Aldo-Keto Reductases and Cancer
Trevor M. Penning et al.
STEROID ENZYMES AND CANCER (2009)
Derivatives of pyrimidine, phthalimide and anthranilic acid as inhibitors of human hydroxysteroid dehydrogenase AKR1C1
P. Brozic et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2009)
New cyclopentane derivatives as inhibitors of steroid metabolizing enzymes AKR1C1 and AKR1C3
Bogdan Stefane et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)
Aldo-keto reductase 1C subfamily genes in skin are UV-inducible: possible role in keratinocytes survival
Yari E. Marin et al.
EXPERIMENTAL DERMATOLOGY (2009)
Human Cytosolic Hydroxysteroid Dehydrogenases of the Aldo-ketoreductase Superfamily Catalyze Reduction of Conjugated Steroids IMPLICATIONS FOR PHASE I AND PHASE II STEROID HORMONE METABOLISM
Yi Jin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Structure-Guided Design, Synthesis, and Evaluation of Salicylic Acid-Based Inhibitors Targeting a Selectivity Pocket in the Active Site of Human 20α-Hydroxysteroid Dehydrogenase (AKR1C1)
Ossama El-Kabbani et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Current smoking-specific gene expression signature in normal bronchial epithelium is enhanced in squamous cell lung cancer
Mirjam C. Boelens et al.
JOURNAL OF PATHOLOGY (2009)
Androgen metabolism in adipose tissue: Recent advances
Karine Blouin et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
Discovery of new inhibitors of aldo-keto reductase 1C1 by structure-based virtual screening
Petra Brozic et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
Disturbed estrogen and progesterone action in ovarian endometriosis
Tina Smuc et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
Aberrant pre-receptor regulation of estrogen and progesterone action in endometrial cancer
Tina Smuc et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
Monolayer and Spheroid Culture of Human Liver Hepatocellular Carcinoma Cell Line Cells Demonstrate Distinct Global Gene Expression Patterns and Functional Phenotypes
Tammy T. Chang et al.
TISSUE ENGINEERING PART A (2009)
Temporal-spatial analysis of US-Mexico border environmental fine and coarse PM air sample extract activity in human bronchial epithelial cells
Fredine T. Lauer et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2009)
AKR1C1 and SRD5A1 Messenger RNA Expression at Term in the Human Myometrium and Chorioamniotic Membranes
Richard H. Lee et al.
AMERICAN JOURNAL OF PERINATOLOGY (2008)
Structure of aldehyde reductase in ternary complex with coenzyme and the potent 20α-hydroxysteroid dehydrogenase inhibitor 3,5-dichlorosalicylic acid: Implications for inhibitor binding and selectivity
Vincenzo Carbone et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2008)
Cadmium, cobalt and lead cause stress response, cell cycle deregulation and increased steroid as well as xenobiotic metabolism in primary normal human bronchial epithelial cells which is coordinated by at least nine transcription factors
Felix Glahn et al.
ARCHIVES OF TOXICOLOGY (2008)
Transcriptional regulation of aldo-keto reductase 1C1 in HT29 human colon cancer cells resistant to methotrexate:: Role in the cell cycle and apoptosis
Elisabet Selga et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Comparisons of (±)-benzo[a]pyrene-trans-7,8-dihydrodiol activation by human cytochrome P450 and aldo-keto reductase enzymes:: Effect of redox state and expression levels
Amy M. Quinn et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2008)
Progesterone is Extensively Metabolized in Osteoblasts: Implications for Progesterone Action on Bone
M. Quinkler et al.
HORMONE AND METABOLIC RESEARCH (2008)
Estrogen and progesterone metabolism in the cervix during pregnancy and parturition
Stefan Andersson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Selectivity determinants of inhibitor binding to human 20α-hydroxysteroid dehydrogenase:: Crystal structure of the enzyme in ternary complex with coenzyme and the potent inhibitor 3,5-dichlorosalicylic acid
Urmi Dhagat et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Diesel exhaust influences carcinogenic PAH-induced genotoxicity and gene expression in human breast epithelial cells in culture
Lauren A. Courter et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2007)
Gene expression profiling of cancer stem cell in human lung adenocarcinoma A549 cells
Dong-Cheol Seo et al.
MOLECULAR CANCER (2007)
Elucidation of a complete kinetic mechanism for a mammalian hydroxysteroid dehydrogenase (HSD) and identification of all enzyme forms on the reaction coordinate -: The example of rat liver 3α-HSD (AKR1C9)
William C. Cooper et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
A salicylic acid-based analogue discovered from virtual screening as a potent inhibitor of human 20α-hydroxysteroid dehydrogenase
Urmi Dhagat et al.
MEDICINAL CHEMISTRY (2007)
Aldo-keto reductases (AKR) from the AKR1C subfamily catalyze the carbonyl reduction of the novel anticancer drug oracin in man
Vladimir Wsol et al.
TOXICOLOGY (2007)
Epithelial ovarian cancer: Disease etiology, treatment, detection, and investigational gene, metabolite, and protein biomarkers
Taufika Islam Williams et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Selectivity determinants of the aldose and aldehyde reductase inhibitor-binding sites
O. El-Kabbani et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Reversal of inflammation-associated dihydrodiol dehydrogenases (AKR1C1 and AKR1C2) overexpression and drug resistance in nonsmall cell lung cancer cells by wogonin and chrysin
Hao-Wei Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
4-Hydroxynonenal, a product of oxidative stress, leads to an antioxidant response in optic nerve head astrocytes
P. E. Malone et al.
EXPERIMENTAL EYE RESEARCH (2007)
Metabolic enzyme induction by HepG2 cells exposed to oxygenated and nonoxygenated polycyclic aromatic hydrocarbons
Kentaro Misaki et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2007)
Impaired dihydrotestosterone catabolism in human prostate cancer: Critical role of AKR1C2 as a pre-receptor regulator of androgen receptor signaling
Qing Ji et al.
CANCER RESEARCH (2007)
Prostaglandin metabolism in human hair follicle
Laurent Colombe et al.
EXPERIMENTAL DERMATOLOGY (2007)
Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men
Karine Blouin et al.
JOURNAL OF ENDOCRINOLOGY (2006)
Transcript profiling of the androgen signal in normal prostate, benign prostatic hyperplasia, and prostate cancer
David R. Bauman et al.
ENDOCRINOLOGY (2006)
Multiple steps determine the overall rate of the reduction of 5α-dihydrotestosterone catalyzed by human type 3 3α-hydroxysteroid dehydrogenase:: Implications for the elimination of androgens
Yi Jin et al.
BIOCHEMISTRY (2006)
Phytoestrogens as inhibitors of the human progesterone metabolizing enzyme AKR1C1
Petra Brozic et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2006)
Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers
M. Woenckhaus et al.
JOURNAL OF PATHOLOGY (2006)
Cigarette smoke condensate induces cytochromes P450 and aldo-keto reductases in oral cancer cells
Nagathihalli S. Nagaraj et al.
TOXICOLOGY LETTERS (2006)
Characteristics and inhibition by flavonoids of 20α-hydroxysteroid dehydrogenase activity in mouse tissues
H Shimada et al.
LIFE SCIENCES (2006)
Screening for ovarian cancer in the general population
CS Chu et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2006)
AKR1C1 and AKR1C3 may determine progesterone and estrogen ratios in endometrial cancer
TL Rizner et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2006)
Tibolone metabolism in human liver is catalyzed by 3α/3β-hydroxysteroid dehydrogenase activities of the four isoforms of the aldo-keto reductase (AKR)1C subfamily
S Steckelbroeck et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Catalytic mechanism and substrate selectivity of aldo-keto reductases: Insights from structure-function studies of Candida tenuis xylose reductase
Regina Kratzer et al.
IUBMB LIFE (2006)
Factorizing selectivity determinants of inhibitor binding toward aldose and aldehyde reductases: Structural and thermodynamic properties of the aldose reductase mutant Leu300Pro-fidarestat complex
T Petrova et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Structure of aldehyde reductase holoenzyme in complex with the potent aldose reductase inhibitor fidarestat: Implications for inhibitor binding and selectivity
O El-Kabbani et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Localization and altered expression of AKR1C family members in human ovarian tissues
Q Ji et al.
MOLECULAR AND CELLULAR PROBES (2005)
Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers' non-small cell lung carcinomas
S Fukumoto et al.
CLINICAL CANCER RESEARCH (2005)
Expression and activity of steroid aldoketoreductases 1C in omental adipose tissue are positive correlates of adiposity in women
K Blouin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Regulation of progesterone levels during pregnancy and parturition by signal transducer and activator of transcription 5 and 20α-hydroxysteroid dehydrogenase
RP Piekorz et al.
MOLECULAR ENDOCRINOLOGY (2005)
Development of nonsteroidal anti-inflammatory drug analogs and steroid carboxylates selective for human aldo-keto reductase isoforms: Potential antineoplastic agents that work independently of cyclooxygenase isozymes
DR Bauman et al.
MOLECULAR PHARMACOLOGY (2005)
Expression and activity of 20 alpha-hydroxysteroid dehydrogenase (AKR1C1) in abdominal subcutaneous and omental adipose tissue in women
S Blanchette et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Human cytosolic 3α-hydroxysteroid dehydrogenases of the aldo-keto reductase superfamily display significant 3β-hydroxysteroid dehydrogenase activity -: Implications for steroid hormone metabolism and action
S Steckelbroeck et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Structure-function of human 3α-hydroxysteroid dehydrogenases:: genes and proteins
TM Penning et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2004)
Carbonyl reduction of naltrexone and dolasetron by oxidoreductases isolated from human liver cytosol
U Breyer-Pfaff et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2004)
Tibolone is metabolized by the 3α/3β-hydroxysteroid dehydrogenase activities of the four human isozymes of the aldo-keto reductase 1C subfamily:: Inversion of stereospecificity with a Δ5(10)-3-ketosteroid
S Steckelbroeck et al.
MOLECULAR PHARMACOLOGY (2004)
Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma
MJ Lewis et al.
BMC CANCER (2004)
The roles of aldo-keto reductases in steroid hormone action
DR Bauman et al.
DRUG NEWS & PERSPECTIVES (2004)
Selective loss of AKR1C1 and AKR1C2 in breast cancer and their potential effect on progesterone signaling
Q Ji et al.
CANCER RESEARCH (2004)
Altered expression of 3 α-hydroxy steroid dehydrogenases in human glaucomatous optic nerve head astrocytes
OA Agapova et al.
NEUROBIOLOGY OF DISEASE (2003)
Human 20α-hydroxysteroid dehydrogenase:: Crystallographic and site-directed mutagenesis studies lead to the identification of an alternative binding site for C21-steroids
JF Couture et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Structure-function relationships in 3α-hydroxysteroid dehydrogenases:: a comparison of the rat and human isoforms
TM Penning et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2003)
Activity and expression of progesterone metabolizing 5α-reductase, 20α-hydroxysteroid oxidoreductase and 3α(β)-hydroxysteroid oxidoreductases in tumorigenic (MCF-7, MDA-MB-231, T-47D) and nontumorigenic (MCF-10A) human breast cancer cells -: art. no. 9
JP Wiebe et al.
BMC CANCER (2003)
Selective and potent inhibitors of human 20α-hydroxysteroid dehydrogenase (AKR1C1) that metabolizes neurosteroids derived from progesterone
Y Higaki et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2003)
Progesterone metabolism in human leukemic monoblast U937 cells
T Suzuki et al.
ENDOCRINE JOURNAL (2002)
Activation of polycyclic aromatic hydrocarbon trans-dihydrodiol proximate carcinogens by human aldo-keto reductase (AKR1C) enzymes and their functional overexpression in human lung carcinoma (A549) cells
NT Palackal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Progesterone receptors - animal models and cell signalling in breast cancer - Diverse activation pathways for the progesterone receptor: possible implications for breast biology and cancer
C Lanari et al.
BREAST CANCER RESEARCH (2002)
Share Paper
